Stack #121109
a MCPHS- Provider I- Ch 41- Assessment &
Management of Pts w/DM
Question Answer
Group of diseases
characterized by
hyperglycemia
Diabetes Mellitus
Hyperglycemia can be
d/t defects in
Insulin secre
...
Stack #121109
a MCPHS- Provider I- Ch 41- Assessment &
Management of Pts w/DM
Question Answer
Group of diseases
characterized by
hyperglycemia
Diabetes Mellitus
Hyperglycemia can be
d/t defects in
Insulin secretion, Insulin action,
Both
Insulin functions r/t
glucose
Transport, Metabolism,
Stimulates storage, Inhibits
breakdown, Signals liver to stop
release
Storage sites of glucose Liver & muscles
Other functions of
insulin
Enhances storage of dietary fat in
adipose tissue, Transport of
amino acids into cells, Inhibits
breakdown of protein and fat
Type 1 DM d/t Autoimmune destruction of Beta
cells in pancreas
2 factors causing Type
2 DM
Decreased sensitivity to insulin
(resistance), Impaired beta cell
function
DM that can be
controlled by diet Type 2 DM
Fasting blood glucose
>
126 mg/dL
Random glucose > 200 mg/dL
Three P's r/t Clinical
Manifestation of DM Polyuria, Polydipsia, Polyphagia
Polydipsia vs.
Polyphagia
Dip:excessive thirst,
Phagia:excessive eating
Dietary goals r/t DM
Optimal nutrition, Meet energy
needs, Reasonable weight,
Prevent wide glucose
fluctuations, Decrease serum
lipids
Diabetic
ketoacidosis(DKA)
caused by
Type I diabetes
Main causes r/t DKA
Noncompliance w/insulin
regimen, Illness/infection,
Undiagnosed/untreated diabetes
Hyperglycemic
Hyperosmolar
Nonketonic
Syndrome(HHNS)
caused by
Type II diaetes
Complication r/t
Diabetes can occur in
anyone w/
Type I and Type II diabetes, Not
only Pts using insulin
Glucagon function Stimulates liver to release
glucose
Pathophysiology
effects r/t Type I
diabetes
Decreased insulin production,
Rampant glucose production by
liver, Fasting hyperglycemia,
Glucose not stored in liver
Ketone bodies are
byproducts of Fat breakdown
S/Sx r/t DKA Abd pain, N/V, Hyperventilation,
Acetone breath(fruity odor)
Insulin problems r/t
Type II diabetes
Insulin resistance, Impaired
insulin secretion
Primary treatment r/t
Type II diabetes Weight loss
Main goal r/t Diabetes
treatment
Normalize insulin activity and
blood glucose levels, Reduce
development of complications
Glycated
hemoglobin(A1C)
reflects
Average blood glucose levels
over the last 2-3 months
A1C binds to RBC's for the cells entire life
Rapid-acting vs. Shortacting vs. IntermediateR:Lispro, S:Regular, I:NPH,
V:Lantus
acting vs. Very longacting r/t Insulin names
Rapid-acting vs. Shortacting vs. Intermediateacting vs. Very longacting r/t Onset period
R:15 min, S:30 min, I:2 hrs, V:1
hr
Insulin regimens goal
Mimic normal pattern of insulin
secretion d/t food intake and
activity patterns
Pt requirements r/t
Complex insulin
regimens
Commitment, Intensive
education, Close follow-up
w/health care team
Complications r/t
Insulin therapy
Local/systemic allergic reactions,
Insulin lipodystrophy, Insulin
resistance, Morning
hyperglycemia
3 types of Morning
hyperglycemia
Dawn phenomenon, Insulin
waning, Somogyi effect
Alternative methods r/t
Insulin delivery
Insulin pen, Jet injector, Insulin
pump, Implantable insulin
delivery, Pancreatic cell
transplants
First skills taught r/t
Newly diagnosed
diabetics
Needle insertion & insulin
injection
Absorption
rates(Fastest to
slowest) r/t Injections
sites
Abd(fastest), arm, thigh,
hip(slowest)
Hypoglycemia r/t
Blood glucose level Less than 60 mg/dL
Hypoglycemia causes Too much insulin or physical
activity, Too little food
Mild vs. Moderate vs.
Severe hypoglycemia
r/t Manefestations
Mild:adrenergic
symptoms(sweating, tremor,
tachycardia, hunger),
Moderate:adrenergic symptoms
plus some CNS impairities,
S:extremely impaired CNS
function(Pt needs assistance)
Immediate treatment r/t
Hypoglycemia
15g fast-acting concentrated
CHO
Emergency treatment
r/t Hypoglycemia 1 mg glucagon
Time r/t Snacking Peak insulin activity
3 main clinical feature
r/t DKA
Hyperglycemia,
Dehydration/electrolyte loss,
Acidosis
DKA treatment factors
that reduce serum K
levels
Rehydration, Insulin
administration
Precipitating events r/t
HHNS
Acute illness, Medications
exacerbating hyperglycemia,
Recent history of polyuria
w/adequate fluid intake
Ketosis & acidosis r/t
HHNS Generally do not occur
Manifestations r/t
HHNS
Hypotension, Severe
dehydration, Tachycardia,
Variable neurologic signs
Initial treatments r/t
DKA & HHNS
Fluid replacement, Correct
electrolyte imbalances, Insulin
administration
Cause r/t Diabetic
retinopathy
Changes in blood vessels of
retina
Autonomic neuropathy
r/t Adrenergic
symptoms of
hypoglycemia
Symptoms are diminshed/absent
Subtle sign r/t
Hypoglycemia
Numbness around mouth,
Difficulty concentrating
Manifestations r/t
Sudomotor neuropathy
Decreased/absence of sweating
in extremities, Increased upper
body sweating
[Show More]